Wherein diabetes-mediated IL-17A production was inhibited by: an anti-IL-17A intravitreal injection in STZ-Type I diabetic mice, weekly intraperitoneal injections of anti-IL-17A in db/db-Type II diabetic mice, or systemically ablated in IL17A-/- STZ-diabetic mice. This evidence concerns the gene IL17A and diabetes mellitus.